Procalcitonin: Where Are We Now?
| dc.contributor.author | Hamade, Bachar | |
| dc.contributor.author | Huang, David Tom | |
| dc.contributor.department | Emergency Medicine | |
| dc.contributor.faculty | Faculty of Medicine (FM) | |
| dc.contributor.institution | American University of Beirut | |
| dc.date.accessioned | 2025-01-24T11:41:40Z | |
| dc.date.available | 2025-01-24T11:41:40Z | |
| dc.date.issued | 2020 | |
| dc.description.abstract | Procalcitonin is a biomarker that is generally elevated in bacterial infections. This review describes a conceptual framework for biomarkers using lessons from the history of troponin, applies this framework to procalcitonin with a review of observational studies and randomized trials in and out of the intensive care unit, and concludes with clinical recommendations and thoughts on how to test a test. © 2019 Elsevier Inc. | |
| dc.identifier.doi | https://doi.org/10.1016/j.ccc.2019.08.003 | |
| dc.identifier.eid | 2-s2.0-85073833500 | |
| dc.identifier.pmid | 31733680 | |
| dc.identifier.uri | http://hdl.handle.net/10938/29834 | |
| dc.language.iso | en | |
| dc.publisher | W.B. Saunders | |
| dc.relation.ispartof | Critical Care Clinics | |
| dc.source | Scopus | |
| dc.subject | Antibiotics | |
| dc.subject | Mortality | |
| dc.subject | Procalcitonin | |
| dc.subject | Respiratory tract infection | |
| dc.subject | Sepsis | |
| dc.subject | Anti-bacterial agents | |
| dc.subject | Biomarkers | |
| dc.subject | Humans | |
| dc.subject | Respiratory tract infections | |
| dc.subject | Antibiotic agent | |
| dc.subject | Antiinfective agent | |
| dc.subject | Troponin | |
| dc.subject | Biological marker | |
| dc.subject | Chronic obstructive lung disease | |
| dc.subject | Community acquired pneumonia | |
| dc.subject | Conceptual framework | |
| dc.subject | Critically ill patient | |
| dc.subject | Evidence based medicine | |
| dc.subject | History | |
| dc.subject | Human | |
| dc.subject | Intensive care unit | |
| dc.subject | Peritonitis | |
| dc.subject | Practice guideline | |
| dc.subject | Prediction | |
| dc.subject | Priority journal | |
| dc.subject | Randomized controlled trial (topic) | |
| dc.subject | Review | |
| dc.subject | Treatment outcome | |
| dc.subject | Blood | |
| dc.title | Procalcitonin: Where Are We Now? | |
| dc.type | Review |
Files
Original bundle
1 - 1 of 1